Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' equity:  
Schedule of stock options issued by the Company
    Options Outstanding     Options Exercisable    

Range of
Exercise Prices

    Weighted-
average
Exercise
price
per
share
   

Intrinsic
Value (1)

Outstanding at January 1, 2018     1,238,199             $ 1.95     $ 385.60     $ 12.47     $78,486
Exercisable at January 1, 2018             567,210                              
Activity during the year ended December 31, 2018                                            
Granted     167,500             $ 1.40     $ 2.18     $ 1.81     $11,050
Cancelled or forfeited     (19,303 )           $ 1.95     $ 385.60     $ 18.77      
Outstanding at December 31, 2018     1,386,396             $ 1.40     $ 385.60     $ 11.09     $11,050
Exercisable at December 31, 2018             973,498                             -
Activity during the year ended December 31, 2019                                            
Granted     256,601             $ 1.65     $ 4.11     $ 3.44     $348,828
Exercised     (3,025 )           $ 1.74     $ 2.60     $ 1.89      
Cancelled or forfeited     (805 )           $ 2.60     $ 385.60     $ 95.37      
Outstanding at December 31, 2019     1,639,167             $ 1.40     $ 83.60     $ 9.87     $2,892,027
Exercisable at December 31, 2019             1,293,121                             $2,244,783

 

  (1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
 
Schedule of stock options (contractual life expressed in years)
      Options Outstanding     Options Exercisable  
Range of Exercise Prices     Number
Outstanding
    Weighted -
Average
Remaining
Contractual
Life
    Weighted -
Average
Exercise
Price Per
Share
    Number
Exercisable
    Weighted -
Average
Remaining
Contractual
Life
    Weighted -
Average
Exercise
Price Per
Share
 
  $1.40-$45.20       1,563,540       7.72     $ 7.01       1,217,494       7.42     $ 8.17  
  $46.40--$83.60       75,627       1.88     $ 69.09       75,627       1.88     $ 69.09  
          1,639,167       7.45     $ 9.87       1,293,121       7.10     $ 11.73  
Schedule of company's nonvested stock options
Nonvested Stock Options   Shares     Weighted -
Average
Per Share
Grant Date
Fair Value
 
Nonvested, January 1, 2018     670,989     $ 1.45  
Activity during the year ended December 31, 2018                
Granted     167,500       0.95  
Forfeited     (15,327 )     25.22  
Vested     (442,879 )     1.71  
Nonvested, December 31, 2018     380,283       0.94  
Activity during the year ended December 31, 2019                
Granted     256,601       1.72  
Exercised     (2,725 )     1.89  
Forfeited     (580 )     42.66  
Vested     (287,533 )     1.35  
Nonvested, December 31, 2019     346,046     $ 1.46  
Schedule of share-based compensation expense
Years Ended December 31,
2019   2018
$    799,111   $    1,231,379
Schedule of assumptions used in calculating the fair value under the Black-Scholes option-pricing model
    Years Ended December 31,  
    2019     2018  
Dividend yield     0%       0%  
Expected Volatility     52.17% to 52.90%       51.58% to 54.21%  
Risk free Interest rates     1.39% to 1.72%       2.77% to 3.00%  
Expected lives (in years)     5.5 to 6.0       5.8  
Schedule of common stock warrant activity
      Shares     Weighted -
Average
Exercise
Price
 
Outstanding at January 1, 2018       8,949,078     $ 4.12  
Activity during the year ended December 31, 2018                  
        Exercised       (221,773 )   $ 2.15  
       Terminated       (50,824 )   $ 6.64  
Outstanding at December 31, 2018       8,676,481     $ 4.17  
Activity during the year ended December 31, 2019                  
       Exercised       (2,928,681 )   $ 2.20  
       Terminated       (215,533 )   $ 35.32  
Outstanding at December 31, 2019       5,532,267     $ 4.00  
Schedule of information regarding outstanding warrants

 Exercise
Price

    Number
Outstanding
    Weighted -
Average
Remaining
Contractual
Life
   

Intrinsic

Value (1)

 
$ 1.83       1,540       0.96     $ 4,574  
$ 2.20       4,025,167       2.40       10,465,434  
$ 5.50       1,110,580       1.67        
$ 16.23       242,021       0.96        
$ 21.10       152,084       0.96        
$ 40.00       875       0.07        
          5,532,267       2.15     $ 10,470,008